nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Infertility—Carmustine—malignant glioma	0.0281	0.043	CcSEcCtD
Cyproterone acetate—Infertility—Temozolomide—malignant glioma	0.0271	0.0415	CcSEcCtD
Cyproterone acetate—Hemiplegia—Carmustine—malignant glioma	0.0205	0.0314	CcSEcCtD
Cyproterone acetate—Hemiplegia—Temozolomide—malignant glioma	0.0198	0.0303	CcSEcCtD
Cyproterone acetate—Personality disorder—Carmustine—malignant glioma	0.017	0.0259	CcSEcCtD
Cyproterone acetate—Pulmonary fibrosis—Carmustine—malignant glioma	0.0167	0.0255	CcSEcCtD
Cyproterone acetate—Pulmonary fibrosis—Temozolomide—malignant glioma	0.0161	0.0246	CcSEcCtD
Cyproterone acetate—Myasthenia—Carmustine—malignant glioma	0.0117	0.0178	CcSEcCtD
Cyproterone acetate—Encephalopathy—Carmustine—malignant glioma	0.0114	0.0175	CcSEcCtD
Cyproterone acetate—Aphasia—Carmustine—malignant glioma	0.0113	0.0173	CcSEcCtD
Cyproterone acetate—Embolism—Temozolomide—malignant glioma	0.011	0.0169	CcSEcCtD
Cyproterone acetate—Cyst—Carmustine—malignant glioma	0.011	0.0168	CcSEcCtD
Cyproterone acetate—Aphasia—Temozolomide—malignant glioma	0.0109	0.0167	CcSEcCtD
Cyproterone acetate—Thrombosis—Carmustine—malignant glioma	0.0104	0.0158	CcSEcCtD
Cyproterone acetate—Endocrine disorder—Temozolomide—malignant glioma	0.00855	0.0131	CcSEcCtD
Cyproterone acetate—Breast pain—Temozolomide—malignant glioma	0.00812	0.0124	CcSEcCtD
Cyproterone acetate—Leukocytosis—Carmustine—malignant glioma	0.0078	0.0119	CcSEcCtD
Cyproterone acetate—Gait disturbance—Carmustine—malignant glioma	0.00751	0.0115	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Carmustine—malignant glioma	0.00733	0.0112	CcSEcCtD
Cyproterone acetate—Injection site reaction—Carmustine—malignant glioma	0.00729	0.0112	CcSEcCtD
Cyproterone acetate—Gait disturbance—Temozolomide—malignant glioma	0.00726	0.0111	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Temozolomide—malignant glioma	0.00708	0.0108	CcSEcCtD
Cyproterone acetate—Coma—Carmustine—malignant glioma	0.0067	0.0102	CcSEcCtD
Cyproterone acetate—Neoplasm—Carmustine—malignant glioma	0.00663	0.0101	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Carmustine—malignant glioma	0.00656	0.01	CcSEcCtD
Cyproterone acetate—Neoplasm—Temozolomide—malignant glioma	0.00641	0.0098	CcSEcCtD
Cyproterone acetate—Abnormal vision—Carmustine—malignant glioma	0.00639	0.00978	CcSEcCtD
Cyproterone acetate—Abnormal vision—Temozolomide—malignant glioma	0.00618	0.00945	CcSEcCtD
Cyproterone acetate—Phlebitis—Carmustine—malignant glioma	0.00618	0.00945	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Carmustine—malignant glioma	0.00615	0.00941	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Carmustine—malignant glioma	0.00612	0.00936	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Temozolomide—malignant glioma	0.00594	0.00909	CcSEcCtD
Cyproterone acetate—Hepatic failure—Temozolomide—malignant glioma	0.00572	0.00876	CcSEcCtD
Cyproterone acetate—Hot flush—Temozolomide—malignant glioma	0.0055	0.00841	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Temozolomide—malignant glioma	0.00545	0.00834	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00545	0.00834	CcSEcCtD
Cyproterone acetate—Affect lability—Temozolomide—malignant glioma	0.00506	0.00774	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Carmustine—malignant glioma	0.00491	0.00752	CcSEcCtD
Cyproterone acetate—Mood swings—Temozolomide—malignant glioma	0.00487	0.00745	CcSEcCtD
Cyproterone acetate—Muscular weakness—Carmustine—malignant glioma	0.00469	0.00718	CcSEcCtD
Cyproterone acetate—Breast disorder—Temozolomide—malignant glioma	0.00465	0.00711	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00463	0.00709	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00454	0.00694	CcSEcCtD
Cyproterone acetate—Muscular weakness—Temozolomide—malignant glioma	0.00454	0.00694	CcSEcCtD
Cyproterone acetate—Sweating increased—Temozolomide—malignant glioma	0.00433	0.00662	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Carmustine—malignant glioma	0.00415	0.00635	CcSEcCtD
Cyproterone acetate—Pollakiuria—Temozolomide—malignant glioma	0.00411	0.00628	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Temozolomide—malignant glioma	0.00409	0.00626	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Temozolomide—malignant glioma	0.00406	0.00621	CcSEcCtD
Cyproterone acetate—Weight increased—Temozolomide—malignant glioma	0.00404	0.00619	CcSEcCtD
Cyproterone acetate—Renal failure—Carmustine—malignant glioma	0.00403	0.00617	CcSEcCtD
Cyproterone acetate—Weight decreased—Temozolomide—malignant glioma	0.00402	0.00615	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Temozolomide—malignant glioma	0.00401	0.00613	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Temozolomide—malignant glioma	0.00375	0.00573	CcSEcCtD
Cyproterone acetate—Haemoglobin—Carmustine—malignant glioma	0.0037	0.00566	CcSEcCtD
Cyproterone acetate—Haemorrhage—Carmustine—malignant glioma	0.00368	0.00563	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Carmustine—malignant glioma	0.00362	0.00554	CcSEcCtD
Cyproterone acetate—Haemoglobin—Temozolomide—malignant glioma	0.00358	0.00547	CcSEcCtD
Cyproterone acetate—Haemorrhage—Temozolomide—malignant glioma	0.00356	0.00544	CcSEcCtD
Cyproterone acetate—Hepatitis—Temozolomide—malignant glioma	0.00356	0.00544	CcSEcCtD
Cyproterone acetate—Visual impairment—Carmustine—malignant glioma	0.00355	0.00543	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Temozolomide—malignant glioma	0.0035	0.00535	CcSEcCtD
Cyproterone acetate—Eye disorder—Carmustine—malignant glioma	0.00344	0.00526	CcSEcCtD
Cyproterone acetate—Visual impairment—Temozolomide—malignant glioma	0.00343	0.00525	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Temozolomide—malignant glioma	0.00336	0.00515	CcSEcCtD
Cyproterone acetate—Eye disorder—Temozolomide—malignant glioma	0.00332	0.00509	CcSEcCtD
Cyproterone acetate—Alopecia—Carmustine—malignant glioma	0.00325	0.00498	CcSEcCtD
Cyproterone acetate—Angiopathy—Temozolomide—malignant glioma	0.00323	0.00494	CcSEcCtD
Cyproterone acetate—Mental disorder—Carmustine—malignant glioma	0.00323	0.00493	CcSEcCtD
Cyproterone acetate—Immune system disorder—Temozolomide—malignant glioma	0.00321	0.00492	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Temozolomide—malignant glioma	0.00321	0.00491	CcSEcCtD
Cyproterone acetate—Malnutrition—Carmustine—malignant glioma	0.0032	0.0049	CcSEcCtD
Cyproterone acetate—Chills—Temozolomide—malignant glioma	0.00319	0.00488	CcSEcCtD
Cyproterone acetate—Alopecia—Temozolomide—malignant glioma	0.00314	0.00481	CcSEcCtD
Cyproterone acetate—Mental disorder—Temozolomide—malignant glioma	0.00312	0.00477	CcSEcCtD
Cyproterone acetate—Malnutrition—Temozolomide—malignant glioma	0.0031	0.00474	CcSEcCtD
Cyproterone acetate—Anaemia—Carmustine—malignant glioma	0.00296	0.00453	CcSEcCtD
Cyproterone acetate—Agitation—Carmustine—malignant glioma	0.00295	0.00451	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Temozolomide—malignant glioma	0.00287	0.0044	CcSEcCtD
Cyproterone acetate—Leukopenia—Carmustine—malignant glioma	0.00287	0.00439	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—SOX2—malignant glioma	0.00286	0.00827	CbGpPWpGaD
Cyproterone acetate—Anaemia—Temozolomide—malignant glioma	0.00286	0.00438	CcSEcCtD
Cyproterone acetate—Agitation—Temozolomide—malignant glioma	0.00285	0.00435	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HES1—malignant glioma	0.00283	0.00816	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—NCOR1—malignant glioma	0.00281	0.00811	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—malignant glioma	0.00281	0.0081	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00279	0.00806	CbGpPWpGaD
Cyproterone acetate—Malaise—Temozolomide—malignant glioma	0.00279	0.00427	CcSEcCtD
Cyproterone acetate—Leukopenia—Temozolomide—malignant glioma	0.00277	0.00424	CcSEcCtD
Cyproterone acetate—Cough—Temozolomide—malignant glioma	0.0027	0.00413	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00262	0.00401	CcSEcCtD
Cyproterone acetate—Oedema—Carmustine—malignant glioma	0.00262	0.004	CcSEcCtD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CAT—malignant glioma	0.00261	0.00752	CbGpPWpGaD
Cyproterone acetate—Discomfort—Temozolomide—malignant glioma	0.00261	0.00399	CcSEcCtD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—malignant glioma	0.00258	0.00746	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—malignant glioma	0.00258	0.00744	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Carmustine—malignant glioma	0.00256	0.00392	CcSEcCtD
Cyproterone acetate—Tachycardia—Carmustine—malignant glioma	0.00255	0.00391	CcSEcCtD
Cyproterone acetate—Oedema—Temozolomide—malignant glioma	0.00253	0.00387	CcSEcCtD
Cyproterone acetate—Anorexia—Carmustine—malignant glioma	0.00249	0.00381	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Temozolomide—malignant glioma	0.00248	0.00379	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Temozolomide—malignant glioma	0.00247	0.00379	CcSEcCtD
Cyproterone acetate—Skin disorder—Temozolomide—malignant glioma	0.00246	0.00376	CcSEcCtD
Cyproterone acetate—Hypotension—Carmustine—malignant glioma	0.00244	0.00374	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Temozolomide—malignant glioma	0.00244	0.00374	CcSEcCtD
Cyproterone acetate—Anorexia—Temozolomide—malignant glioma	0.00241	0.00369	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—malignant glioma	0.00239	0.00689	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00237	0.00685	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HIF1A—malignant glioma	0.00237	0.00684	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Carmustine—malignant glioma	0.00233	0.00357	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.0023	0.00664	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—RAF1—malignant glioma	0.00229	0.0066	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Carmustine—malignant glioma	0.00227	0.00348	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—KDR—malignant glioma	0.00227	0.00654	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00226	0.00345	CcSEcCtD
Cyproterone acetate—Dyspnoea—Temozolomide—malignant glioma	0.00225	0.00345	CcSEcCtD
Cyproterone acetate—Constipation—Carmustine—malignant glioma	0.00224	0.00342	CcSEcCtD
Cyproterone acetate—Dyspepsia—Temozolomide—malignant glioma	0.00222	0.0034	CcSEcCtD
Cyproterone acetate—Decreased appetite—Temozolomide—malignant glioma	0.0022	0.00336	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—RAF1—malignant glioma	0.0022	0.00634	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00218	0.00334	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00218	0.00629	CbGpPWpGaD
Cyproterone acetate—Fatigue—Temozolomide—malignant glioma	0.00218	0.00333	CcSEcCtD
Cyproterone acetate—Constipation—Temozolomide—malignant glioma	0.00216	0.00331	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Carmustine—malignant glioma	0.00216	0.0033	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.00215	0.00619	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Carmustine—malignant glioma	0.00214	0.00327	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—NOTCH1—malignant glioma	0.00213	0.00616	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.0021	0.00607	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Temozolomide—malignant glioma	0.00208	0.00319	CcSEcCtD
Cyproterone acetate—Body temperature increased—Carmustine—malignant glioma	0.00207	0.00316	CcSEcCtD
Cyproterone acetate—Abdominal pain—Carmustine—malignant glioma	0.00207	0.00316	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00207	0.00316	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00201	0.00581	CbGpPWpGaD
Cyproterone acetate—Urticaria—Temozolomide—malignant glioma	0.00201	0.00307	CcSEcCtD
Cyproterone acetate—Abdominal pain—Temozolomide—malignant glioma	0.002	0.00306	CcSEcCtD
Cyproterone acetate—Body temperature increased—Temozolomide—malignant glioma	0.002	0.00306	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00194	0.00561	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Carmustine—malignant glioma	0.00193	0.00295	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2B6—malignant glioma	0.00192	0.00554	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00192	0.00554	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.0019	0.00549	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00189	0.00546	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00189	0.00545	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—NCOR1—malignant glioma	0.00188	0.00543	CbGpPWpGaD
Cyproterone acetate—Asthenia—Carmustine—malignant glioma	0.00188	0.00287	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Temozolomide—malignant glioma	0.00186	0.00285	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.00185	0.00533	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00182	0.00525	CbGpPWpGaD
Cyproterone acetate—Asthenia—Temozolomide—malignant glioma	0.00181	0.00277	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—malignant glioma	0.00181	0.00523	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.00181	0.00523	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Carmustine—malignant glioma	0.00179	0.00274	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—GJA1—malignant glioma	0.00179	0.00516	CbGpPWpGaD
Cyproterone acetate—Pruritus—Temozolomide—malignant glioma	0.00179	0.00274	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00178	0.00513	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.00174	0.00504	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00174	0.00503	CbGpPWpGaD
Cyproterone acetate—Dizziness—Carmustine—malignant glioma	0.00173	0.00265	CcSEcCtD
Cyproterone acetate—Diarrhoea—Temozolomide—malignant glioma	0.00173	0.00265	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTK2—malignant glioma	0.00173	0.00499	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—NCOR1—malignant glioma	0.00169	0.00487	CbGpPWpGaD
Cyproterone acetate—Dizziness—Temozolomide—malignant glioma	0.00167	0.00256	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2C18—malignant glioma	0.00166	0.0048	CbGpPWpGaD
Cyproterone acetate—Vomiting—Carmustine—malignant glioma	0.00166	0.00254	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00165	0.00477	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00165	0.00477	CbGpPWpGaD
Cyproterone acetate—Rash—Carmustine—malignant glioma	0.00165	0.00252	CcSEcCtD
Cyproterone acetate—Dermatitis—Carmustine—malignant glioma	0.00165	0.00252	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00164	0.00474	CbGpPWpGaD
Cyproterone acetate—Headache—Carmustine—malignant glioma	0.00164	0.00251	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00164	0.00473	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—malignant glioma	0.00162	0.00467	CbGpPWpGaD
Cyproterone acetate—Vomiting—Temozolomide—malignant glioma	0.00161	0.00246	CcSEcCtD
Cyproterone acetate—Rash—Temozolomide—malignant glioma	0.00159	0.00244	CcSEcCtD
Cyproterone acetate—Dermatitis—Temozolomide—malignant glioma	0.00159	0.00244	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—HIF1A—malignant glioma	0.00159	0.00458	CbGpPWpGaD
Cyproterone acetate—Headache—Temozolomide—malignant glioma	0.00158	0.00242	CcSEcCtD
Cyproterone acetate—Nausea—Carmustine—malignant glioma	0.00155	0.00238	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00153	0.00442	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00153	0.00441	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00151	0.00436	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00151	0.00436	CbGpPWpGaD
Cyproterone acetate—Nausea—Temozolomide—malignant glioma	0.0015	0.0023	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00149	0.00431	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—malignant glioma	0.00149	0.0043	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00147	0.00426	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00147	0.00425	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00145	0.0042	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—MDM2—malignant glioma	0.00144	0.00415	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00143	0.00413	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00138	0.00398	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—malignant glioma	0.00138	0.00397	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CAV1—malignant glioma	0.00138	0.00397	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HLA-A—malignant glioma	0.00137	0.00395	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—malignant glioma	0.00136	0.00394	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—malignant glioma	0.00136	0.00393	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00135	0.00389	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTT1—malignant glioma	0.00135	0.00388	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HIF1A—malignant glioma	0.00131	0.00377	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—PTGS1—malignant glioma	0.00126	0.00364	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00124	0.00358	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—malignant glioma	0.00124	0.00357	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—malignant glioma	0.00121	0.00349	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—NOTCH1—malignant glioma	0.00121	0.00348	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APC—malignant glioma	0.00118	0.0034	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00118	0.00339	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00115	0.00331	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00115	0.00331	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00113	0.00327	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—malignant glioma	0.00111	0.00321	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—malignant glioma	0.00111	0.0032	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00108	0.00313	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—malignant glioma	0.00107	0.00308	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00105	0.00302	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00101	0.00292	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—malignant glioma	0.001	0.0029	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—MDM2—malignant glioma	0.000986	0.00285	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000974	0.00281	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000965	0.00279	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.000945	0.00273	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—RTEL1—malignant glioma	0.000943	0.00272	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000942	0.00272	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.000935	0.0027	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTP1—malignant glioma	0.000932	0.00269	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTP1—malignant glioma	0.00092	0.00265	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.000912	0.00263	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—malignant glioma	0.000908	0.00262	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000907	0.00262	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000877	0.00253	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.000848	0.00245	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.000847	0.00245	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—malignant glioma	0.000829	0.00239	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000822	0.00237	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.00081	0.00234	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.000803	0.00232	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.000799	0.00231	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.000797	0.0023	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000784	0.00226	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.000771	0.00223	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.000767	0.00221	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.000762	0.0022	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—malignant glioma	0.000751	0.00217	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.000747	0.00216	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000743	0.00215	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—malignant glioma	0.000742	0.00214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.000729	0.0021	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.000714	0.00206	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000702	0.00203	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000688	0.00199	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00068	0.00196	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—malignant glioma	0.000677	0.00196	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—malignant glioma	0.000674	0.00195	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000674	0.00194	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000672	0.00194	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.000664	0.00192	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.000656	0.00189	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000652	0.00188	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—malignant glioma	0.000647	0.00187	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.000646	0.00187	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000637	0.00184	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	0.000634	0.00183	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000622	0.0018	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000589	0.0017	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000578	0.00167	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000572	0.00165	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000565	0.00163	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.000564	0.00163	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000564	0.00163	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000563	0.00163	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000558	0.00161	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.000556	0.00161	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000543	0.00157	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000543	0.00157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COX8A—malignant glioma	0.000541	0.00156	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000535	0.00155	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000534	0.00154	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000528	0.00152	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	0.00052	0.0015	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000516	0.00149	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000515	0.00149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000498	0.00144	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000491	0.00142	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000484	0.0014	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00048	0.00138	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000479	0.00138	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000478	0.00138	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—malignant glioma	0.000478	0.00138	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000472	0.00136	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000467	0.00135	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ASMT—malignant glioma	0.00046	0.00133	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	0.000458	0.00132	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NCOR1—malignant glioma	0.000455	0.00131	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000451	0.0013	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00045	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00045	0.0013	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000447	0.00129	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000442	0.00127	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCAN—malignant glioma	0.000433	0.00125	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000428	0.00124	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000427	0.00123	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT3B—malignant glioma	0.000425	0.00123	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000423	0.00122	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000422	0.00122	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000417	0.0012	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—malignant glioma	0.000416	0.0012	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HIST1H3B—malignant glioma	0.000413	0.00119	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—malignant glioma	0.00041	0.00118	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000407	0.00117	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000391	0.00113	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000389	0.00112	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	0.000387	0.00112	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.00038	0.0011	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000374	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000371	0.00107	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000366	0.00106	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000364	0.00105	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000363	0.00105	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—malignant glioma	0.00036	0.00104	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000359	0.00104	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—IDH2—malignant glioma	0.000349	0.00101	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000348	0.00101	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000346	0.000998	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000345	0.000997	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000345	0.000996	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000329	0.00095	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.000328	0.000947	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—malignant glioma	0.000326	0.000941	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000323	0.000931	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000319	0.000921	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—H3F3A—malignant glioma	0.000319	0.000921	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000318	0.000917	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000313	0.000904	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000313	0.000904	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000311	0.000897	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000307	0.000887	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—IDH1—malignant glioma	0.0003	0.000866	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH3—malignant glioma	0.0003	0.000865	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SPHK1—malignant glioma	0.00029	0.000838	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.000284	0.000821	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000269	0.000778	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH2—malignant glioma	0.000269	0.000775	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000268	0.000774	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000262	0.000756	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000259	0.000749	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000247	0.000714	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000244	0.000705	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—H3F3A—malignant glioma	0.000242	0.000699	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000236	0.000681	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CDKN2B—malignant glioma	0.000231	0.000666	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—malignant glioma	0.00023	0.000664	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.000227	0.000656	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOR1—malignant glioma	0.000219	0.000632	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000216	0.000622	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000215	0.00062	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000204	0.000588	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCHE—malignant glioma	0.0002	0.000578	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.000198	0.000571	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000187	0.00054	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—malignant glioma	0.000186	0.000536	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000185	0.000535	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000175	0.000506	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH1—malignant glioma	0.000166	0.00048	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOR1—malignant glioma	0.000166	0.00048	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000162	0.000467	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—malignant glioma	0.000159	0.00046	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—malignant glioma	0.000157	0.000453	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAT—malignant glioma	0.000155	0.000448	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOR1—malignant glioma	0.000147	0.000423	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	0.000141	0.000407	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH1—malignant glioma	0.000126	0.000364	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—malignant glioma	0.000119	0.000345	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—malignant glioma	0.000119	0.000344	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000114	0.000329	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—malignant glioma	0.000109	0.000314	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—malignant glioma	0.000105	0.000303	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—malignant glioma	9.56e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—malignant glioma	8.95e-05	0.000258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—malignant glioma	8.34e-05	0.000241	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—malignant glioma	8.26e-05	0.000238	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—malignant glioma	7.2e-05	0.000208	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—malignant glioma	6.79e-05	0.000196	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—malignant glioma	6.2e-05	0.000179	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—malignant glioma	5.08e-05	0.000147	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—malignant glioma	4.71e-05	0.000136	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—malignant glioma	4.15e-05	0.00012	CbGpPWpGaD
